Smeraglio, Riccardo (2021) Development of an integrable RNA based Gene Panel for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer Patients. [Tesi di dottorato]

[thumbnail of smeraglio_riccardo_33.pdf]
Preview
Text
smeraglio_riccardo_33.pdf

Download (876kB) | Preview
Item Type: Tesi di dottorato
Resource language: English
Title: Development of an integrable RNA based Gene Panel for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer Patients
Creators:
Creators
Email
Smeraglio, Riccardo
riccardosmeraglio@hotmail.it
Date: 1 February 2021
Number of Pages: 35
Institution: Università degli Studi di Napoli Federico II
Department: Sanità Pubblica
Dottorato: Sanità pubblica e medicina preventiva
Ciclo di dottorato: 33
Coordinatore del Corso di dottorato:
nome
email
Troncone, Giancarlo
giancarlo.troncone@unina.it
Tutor:
nome
email
Troncone, Giancarlo
UNSPECIFIED
Date: 1 February 2021
Number of Pages: 35
Keywords: NSCLC; ALK; NTRK; RET; MET; ROS1; Gene Fusion; Gene Arrangement; IHC; FISH; NGS;
Settori scientifico-disciplinari del MIUR: Area 06 - Scienze mediche > MED/08 - Anatomia patologica
Date Deposited: 22 Feb 2021 11:54
Last Modified: 07 Jun 2023 11:07
URI: http://www.fedoa.unina.it/id/eprint/14027

Collection description

Non-small cell lung cancer (NSCLC) still represents the main cause of cancer mortality worldwide. However, targeted treatments have significantly improved the clinical outcome of those patients with non-squamous NSCLC harboring not only point mutations and indertions/deletions (indels), but also gene rearrangements. Currently, immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) are considered the "gold standard" methodologies for the identification of these genomic alterations but feature some technical and interpretative limitations. Therefore, the aim of this study is to validate a novel narrow custom next generation sequencing gene panel, termed SiRe gene fusion panel, able to detect gene rearrangements and other aberrations (such MET exon 14 skipping) for the administration of specific tyrosine kinase inhibitors.

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item